scalable biomanufacturing

Cellino is a regenerative medicine company developing a proprietary technology stack for personalized, patient-specific biomanufacturing. Its AI-driven optical bioprocesses and Nebula™ platform enable scalable production of biologically younger, living medicines—one-time treatments for chronic degenerative conditions—using self-sourced therapies that eliminate the need for immunosuppression.

Read more

AI-driven optical bioprocessesclosed-loop image-guided bioprocessingdeep learning algorithmsin silico simulationlaser cell management